Hu19 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hu19 CAR-T cell therapy, covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies [Phase 1, Phase 2]